Literature DB >> 8041178

Vitamin E for coronary bypass operations. A prospective, double-blind, randomized trial.

T M Yau1, R D Weisel, D A Mickle, G W Burton, K U Ingold, J Ivanov, M K Mohabeer, L Tumiati, S Carson.   

Abstract

BACKGROUND: Free radical lipid peroxidation contributes to the abnormal metabolism and ventricular function frequently seen after cardiac operations. Antioxidants may improve metabolic and functional recovery.
METHODS: A prospective, randomized, double-blind clinical trial was conducted to determine the effects of vitamin E (alpha-tocopherol) (n = 14) or a corn oil placebo (n = 14) in patients undergoing elective coronary bypass operations. The RRR-alpha-tocopheryl acetate doubled the alpha-tocopherol levels in the heart. Myocardial metabolism and ventricular function were assessed after the operation.
RESULTS: Atrial pacing induced myocardial lactate production in the control patients but lactate consumption in the alpha-tocopherol-treated patients on bypass 25 minutes after crossclamp release. Left ventricular stroke work indices were higher, at similar ventricular volumes, in the alpha-tocopherol-treated group, which indicates improved preload recruitable stroke work, and diastolic compliance was greater 4 hours after the operation. The postoperative creatine kinase cardiac isoenzyme levels were lower in the patients who received alpha-tocopherol.
CONCLUSIONS: Pretreatment with alpha-tocopherol sufficient to double the myocardial concentrations had a small but significant metabolic and functional effect after elective coronary bypass operations when compared with placebo. These results do not justify pretreatment of low-risk patients, but they do justify an evaluation in high-risk patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041178

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  3 in total

1.  Does Lethal Reperfusion Injury Exist in Cardiac Surgery?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

Review 2.  Controlling Reperfusion Injury With Controlled Reperfusion: Historical Perspectives and New Paradigms.

Authors:  Demetria M Fischesser; Bin Bo; Rachel P Benton; Haili Su; Newsha Jahanpanah; Kevin J Haworth
Journal:  J Cardiovasc Pharmacol Ther       Date:  2021-09-17       Impact factor: 2.457

3.  α-Tocopherol preserves cardiac function by reducing oxidative stress and inflammation in ischemia/reperfusion injury.

Authors:  Maria Wallert; Melanie Ziegler; Xiaowei Wang; Ana Maluenda; Xiaoqiu Xu; May Lin Yap; Roman Witt; Corey Giles; Stefan Kluge; Marcus Hortmann; Jianxiang Zhang; Peter Meikle; Stefan Lorkowski; Karlheinz Peter
Journal:  Redox Biol       Date:  2019-08-06       Impact factor: 11.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.